Establishing benchmarks and metrics for disruptive technologies, inappropriate and obsolete tests in the clinical laboratory

Abstract Benchmarks and metrics related to laboratory test utilization are based on evidence-based medical literature that may suffer from a positive publication bias. Guidelines are only as good as the data reviewed to create them. Disruptive technologies require time for appropriate use to be established before utilization review will be meaningful. Metrics include monitoring the use of obsolete tests and the inappropriate use of lab tests. Test utilization by clients in a hospital outreach program can be used to monitor the impact of new clients on lab workload. A multi-disciplinary laboratory utilization committee is the most effective tool for modifying bad habits, and reviewing and approving new tests for the lab formulary or by sending them out to a reference lab.

[1]  Biomarkers in cardiovascular medicine: the shame of publication bias. , 2013, JAMA internal medicine.

[2]  Razelle Kurzrock,et al.  Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative , 2012, Clinical Cancer Research.

[3]  B. Branson,et al.  Comparison of alternative interpretive criteria for the HIV-1 Western blot and results of the Multispot HIV-1/HIV-2 Rapid Test for classifying HIV-1 and HIV-2 infections. , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[4]  Hospital laboratory outreach: benefits and planning. , 2007, Clinics in laboratory medicine.

[5]  D. Leland,et al.  Role of Cell Culture for Virus Detection in the Age of Technology , 2007, Clinical Microbiology Reviews.

[6]  Fabrício F. Costa,et al.  DataGenno : building a new tool to bridge molecular and clinical genetics , 2011 .

[7]  D. Dietzen,et al.  National academy of clinical biochemistry laboratory medicine practice guidelines: follow-up testing for metabolic disease identified by expanded newborn screening using tandem mass spectrometry; executive summary. , 2009, Clinical chemistry.

[8]  J. Mahony.  Detection of Respiratory Viruses by Molecular Methods , 2008, Clinical Microbiology Reviews.

[9]  Irwin Klein,et al.  Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. , 2012, Thyroid : official journal of the American Thyroid Association.

[10]  Ira Schwartz,et al.  Diagnosis of Lyme Borreliosis , 2005, Clinical Microbiology Reviews.

[11]  L. Thienpont,et al.  Use of frozen sera for FT4 standardization: investigation by equilibrium dialysis combined with isotope dilution-mass spectrometry and immunoassay. , 2006, Clinical chemistry.

[12]  Robin Patel,et al.  Comparison of Bacterial Antigen Test and Gram Stain for Detecting Classic Meningitis Bacteria in Cerebrospinal Fluid , 2010, Journal of Clinical Microbiology.

[13]  G. Giaccone,et al.  Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. , 2013, Archives of pathology & laboratory medicine.

[14]  Victor M Montori,et al.  Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. , 2011, Thyroid : official journal of the American Thyroid Association.

[15]  M. Linder,et al.  Laboratory Analysis and Application of Pharmacogenetics to Clinical Practice , 2005 .

[16]  Shashikant Kulkarni,et al.  Assuring the quality of next-generation sequencing in clinical laboratory practice , 2012, Nature Biotechnology.

[17]  Pim M W Janssens,et al.  Managing the demand for laboratory testing: options and opportunities. , 2010, Clinica chimica acta; international journal of clinical chemistry.

[18]  R. Marttila,et al.  Diagnosis of enteroviral meningitis by use of polymerase chain reaction of cerebrospinal fluid, stool, and serum specimens. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  W. Smellie,et al.  Demand management and test request rationalization , 2012, Annals of clinical biochemistry.

[20]  C. McMurray.  Mechanisms of trinucleotide repeat instability during human development , 2010, Nature Reviews Genetics.

[21]  J. Warren,et al.  Laboratory test utilization program: structure and impact in a large academic medical center. , 2013, American journal of clinical pathology.

[22]  K. Kinzler,et al.  Cancer Genome Landscapes , 2013, Science.

[23]  J. Ioannidis,et al.  Bias in associations of emerging biomarkers with cardiovascular disease. , 2013, JAMA internal medicine.

[24]  T L Lincoln,et al.  Ready! Fire! . . . Aim! An inquiry into laboratory test ordering. , 1983, JAMA.

[25]  M. Kale,et al.  "Top 5" lists top $5 billion. , 2011, Archives of internal medicine.

[26]  Alexis B. Carter.  Clinical requests for molecular tests: the 3-step evidence check. , 2012, Archives of pathology & laboratory medicine.

[27]  M. Guan.  Frequency, Causes, and New Challenges of Indeterminate Results in Western Blot Confirmatory Testing for Antibodies to Human Immunodeficiency Virus , 2007, Clinical and Vaccine Immunology.

[28]  A. Hauschild,et al.  Improved survival with vemurafenib in melanoma with BRAF V600E mutation. , 2011, The New England journal of medicine.

[29]  J. Iredell,et al.  Current status of matrix-assisted laser desorption ionisation-time of flight mass spectrometry in the clinical microbiology laboratory , 2013, Pathology.

[30]  J. Ketelslegers,et al.  Comparison of three free T4 (FT4) and free T3 (FT3) immunoassays in healthy subjects and patients with thyroid diseases and severe non-thyroidal illnesses. , 2012, Clinical laboratory.

[31]  Anthony Rhodes,et al.  American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). , 2010, Archives of pathology & laboratory medicine.

[32]  L. Hilborne.  When less is more for patients in laboratory testing. , 2013, American journal of clinical pathology.

[33]  M. Guyer,et al.  Charting a course for genomic medicine from base pairs to bedside , 2011, Nature.

[34]  A. Fox,et al.  Mass spectrometry and tandem mass spectrometry characterization of protein patterns, protein markers and whole proteomes for pathogenic bacteria. , 2013, Journal of microbiological methods.

[35]  G D Lundberg,et al.  Changing physician behavior in ordering diagnostic tests. , 1998, JAMA.

[36]  A. Schuchat,et al.  Infections in International Pregnancy Study: Performance of the Optical Immunoassay Test for Detection of Group B Streptococcus , 2003, Journal of Clinical Microbiology.

[37]  M. Thomas,et al.  A REAPPRAISAL OF THE FREE THYROXINE INDEX , 1981, The Lancet.

[38]  A. Schuchat,et al.  PREVENTION OF PERINATAL GROUP B STREPTOCOCCAL DISEASE , 2002 .

[39]  Wei Wang,et al.  SNVerGUI: a desktop tool for variant analysis of next-generation sequencing data , 2012, Journal of Medical Genetics.

[40]  B. Smith,et al.  Pathology resident and fellow education in a time of disruptive technologies. , 2012, Clinics in laboratory medicine.

[41]  B. Skipper,et al.  Professional review of laboratory utilization. , 1982, Human pathology.

[42]  S. J. Henley,et al.  Invasive Cancer Incidence — United States, 2009 , 2013, MMWR. Morbidity and mortality weekly report.

[43]  J. M. Crawford,et al.  A national agenda for the future of pathology in personalized medicine: report of the proceedings of a meeting at the Banbury Conference Center on genome-era pathology, precision diagnostics, and preemptive care: a stakeholder summit. , 2011, American journal of clinical pathology.

[44]  M. Perkins,et al.  Rapid bacterial antigen detection is not clinically useful , 1995, Journal of clinical microbiology.

[45]  R. Seethala,et al.  A combined molecular‐pathologic score improves risk stratification of thyroid papillary microcarcinoma , 2012, Cancer.

[46]  C. Naylor,et al.  Do we know what inappropriate laboratory utilization is? A systematic review of laboratory clinical audits. , 1998, JAMA.

[47]  Kent Lewandrowski,et al.  Managing utilization of new diagnostic tests. , 2003, Clinical leadership & management review : the journal of CLMA.

[48]  O. Bader.  MALDI‐TOF‐MS‐based species identification and typing approaches in medical mycology , 2013, Proteomics.

[49]  R. H. Albert,et al.  Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. , 2010 .

[50]  James Hadfield,et al.  The role of high-throughput technologies in clinical cancer genomics , 2013, Expert review of molecular diagnostics.

[51]  Karl V Voelkerding,et al.  Developing genome and exome sequencing for candidate gene identification in inherited disorders: an integrated technical and bioinformatics approach. , 2013, Archives of pathology & laboratory medicine.

[52]  A Langlands,et al.  Implementing clinical practice guidelines , 1998, The Medical journal of Australia.

[53]  S. Owen,et al.  Evaluation of an alternative HIV diagnostic algorithm using specimens from seroconversion panels and persons with established HIV infections. , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[54]  R. Negro,et al.  2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. , 2011, Thyroid : official journal of the American Thyroid Association.

[55]  Kenny Q. Ye,et al.  An integrated map of genetic variation from 1,092 human genomes , 2012, Nature.

[56]  Anthony Rhodes,et al.  American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. , 2010, Archives of pathology & laboratory medicine.

[57]  B. Yawn,et al.  Diagnosis and management of von Willebrand disease: guidelines for primary care. , 2009, American family physician.

[58]  P. Chavez,et al.  Evaluation of the performance of the Abbott ARCHITECT HIV Ag/Ab Combo Assay. , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[59]  Frederick L. Kiechle,et al.  Outreach Implementation Requirements: A Case Study , 2004 .

[60]  M. Fukunaga,et al.  Guidelines for the use of bone metabolic markers in the diagnosis and treatment of osteoporosis (2012 edition) , 2012, Journal of Bone and Mineral Metabolism.